• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型戈谢病患者成纤维细胞诱导多能干细胞衍生神经元的特性:在神经病理学中的潜在作用。

Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology.

作者信息

Sun Ying, Florer Jane, Mayhew Christopher N, Jia Zhanfeng, Zhao Zhiying, Xu Kui, Ran Huimin, Liou Benjamin, Zhang Wujuan, Setchell Kenneth D R, Gu Jianguo, Grabowski Gregory A

机构信息

Division of Human Genetics, Cincinnati Children's Hospital Research Foundation, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America.

Division of Human Genetics, Cincinnati Children's Hospital Research Foundation, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America.

出版信息

PLoS One. 2015 Mar 30;10(3):e0118771. doi: 10.1371/journal.pone.0118771. eCollection 2015.

DOI:10.1371/journal.pone.0118771
PMID:25822147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4378893/
Abstract

Gaucher disease (GD) is caused by insufficient activity of acid β-glucosidase (GCase) resulting from mutations in GBA1. To understand the pathogenesis of the neuronopathic GD, induced pluripotent stem cells (iPSCs) were generated from fibroblasts isolated from three GD type 2 (GD2) and 2 unaffected (normal and GD carrier) individuals. The iPSCs were converted to neural precursor cells (NPCs) which were further differentiated into neurons. Parental GD2 fibroblasts as well as iPSCs, NPCs, and neurons had similar degrees of GCase deficiency. Lipid analyses showed increases of glucosylsphingosine and glucosylceramide in the GD2 cells. In addition, GD2 neurons showed increased α-synuclein protein compared to control neurons. Whole cell patch-clamping of the GD2 and control iPSCs-derived neurons demonstrated excitation characteristics of neurons, but intriguingly, those from GD2 exhibited consistently less negative resting membrane potentials with various degree of reduction in action potential amplitudes, sodium and potassium currents. Culture of control neurons in the presence of the GCase inhibitor (conduritol B epoxide) recapitulated these findings, providing a functional link between decreased GCase activity in GD and abnormal neuronal electrophysiological properties. To our knowledge, this study is first to report abnormal electrophysiological properties in GD2 iPSC-derived neurons that may underlie the neuropathic phenotype in Gaucher disease.

摘要

戈谢病(GD)是由GBA1基因突变导致酸性β-葡萄糖苷酶(GCase)活性不足引起的。为了解神经病变型GD的发病机制,从三名2型戈谢病(GD2)患者以及两名未受影响(正常人和GD携带者)个体分离出的成纤维细胞中生成了诱导多能干细胞(iPSC)。这些iPSC被转化为神经前体细胞(NPC),并进一步分化为神经元。亲代GD2成纤维细胞以及iPSC、NPC和神经元的GCase缺乏程度相似。脂质分析显示,GD2细胞中的葡萄糖神经鞘氨醇和葡萄糖神经酰胺增加。此外,与对照神经元相比,GD2神经元的α-突触核蛋白水平升高。对GD2和对照iPSC来源的神经元进行全细胞膜片钳记录,结果显示了神经元的兴奋特性,但有趣的是,GD2来源的神经元静息膜电位始终较负,动作电位幅度、钠电流和钾电流均有不同程度的降低。在GCase抑制剂(环硫醇环氧物)存在的情况下培养对照神经元,重现了这些发现,这表明GD中GCase活性降低与异常的神经元电生理特性之间存在功能联系。据我们所知,本研究首次报道了GD2 iPSC来源的神经元存在异常电生理特性,这可能是戈谢病神经病变表型的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d021/4378893/dff93c2d7d38/pone.0118771.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d021/4378893/a35f326535a3/pone.0118771.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d021/4378893/98fc48fb8532/pone.0118771.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d021/4378893/bad5faa6980e/pone.0118771.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d021/4378893/dff93c2d7d38/pone.0118771.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d021/4378893/a35f326535a3/pone.0118771.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d021/4378893/98fc48fb8532/pone.0118771.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d021/4378893/bad5faa6980e/pone.0118771.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d021/4378893/dff93c2d7d38/pone.0118771.g004.jpg

相似文献

1
Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology.2型戈谢病患者成纤维细胞诱导多能干细胞衍生神经元的特性:在神经病理学中的潜在作用。
PLoS One. 2015 Mar 30;10(3):e0118771. doi: 10.1371/journal.pone.0118771. eCollection 2015.
2
A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.一种新型葡萄糖脑苷脂酶伴侣可降低戈谢病和帕金森综合征患者诱导多能干细胞衍生的多巴胺能神经元中的α-突触核蛋白和糖脂水平。
J Neurosci. 2016 Jul 13;36(28):7441-52. doi: 10.1523/JNEUROSCI.0636-16.2016.
3
Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells.从基于细胞的筛选中鉴定出新型的β-葡糖脑苷脂酶伴侣化合物,可减少 iPS 衍生神经元细胞中病理性积累的葡糖基神经酰胺。
SLAS Discov. 2023 Oct;28(7):344-349. doi: 10.1016/j.slasd.2023.06.002. Epub 2023 Jun 25.
4
A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson's disease.Gaucher 诱导多能干细胞衍生的星形胶质细胞的特征:对帕金森病的潜在影响。
Neurobiol Dis. 2020 Feb;134:104647. doi: 10.1016/j.nbd.2019.104647. Epub 2019 Nov 10.
5
Intravenous infusion of iPSC-derived neural precursor cells increases acid β-glucosidase function in the brain and lessens the neuronopathic phenotype in a mouse model of Gaucher disease.静脉输注 iPSC 源性神经前体细胞可增加脑内酸性 β-葡萄糖苷酶的功能,并减轻戈谢病小鼠模型中的神经病变表型。
Hum Mol Genet. 2019 Oct 15;28(20):3406-3421. doi: 10.1093/hmg/ddz184.
6
Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson's disease.酸性鞘磷脂酶参与导致 GBA1 相关帕金森病 iPSC 模型中α-突触核蛋白积累的致病级联反应。
Hum Mol Genet. 2023 May 18;32(11):1888-1900. doi: 10.1093/hmg/ddad025.
7
Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.神经元神经节苷脂贮积病小鼠模型:存活的联合选择性脑苷脂激活蛋白 C 缺乏症和突变型葡萄糖脑苷脂酶(V394L)小鼠,其具有神经鞘氨醇葡萄糖苷和神经鞘氨醇葡萄糖苷脂的累积和进行性神经功能缺损。
Hum Mol Genet. 2010 Mar 15;19(6):1088-97. doi: 10.1093/hmg/ddp580. Epub 2010 Jan 4.
8
Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1.戈谢病诱导多能干细胞神经元中葡萄糖神经酰胺的升高通过雷帕霉素靶蛋白复合物 1 使溶酶体区室失调。
Stem Cells Transl Med. 2021 Jul;10(7):1081-1094. doi: 10.1002/sctm.20-0386. Epub 2021 Mar 3.
9
Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration.神经元葡萄糖脑苷脂在神经病变型戈谢病小鼠模型中的积累导致神经退行性变。
Hum Mol Genet. 2014 Feb 15;23(4):843-54. doi: 10.1093/hmg/ddt468. Epub 2013 Sep 24.
10
Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease.采用液相色谱-串联质谱法对葡萄糖神经酰胺和葡萄糖神经鞘氨醇进行定量分析,为神经病变型戈谢病的体内临床前研究提供支持。
Anal Chem. 2017 Aug 15;89(16):8288-8295. doi: 10.1021/acs.analchem.7b01442. Epub 2017 Jul 26.

引用本文的文献

1
Induced Pluripotent Stem Cells for the Treatment of Lysosomal Storage Disorders.诱导多能干细胞用于溶酶体贮积症的治疗
J Inherit Metab Dis. 2025 Jul;48(4):e70064. doi: 10.1002/jimd.70064.
2
Current opinion on pluripotent stem cell technology in Gaucher's disease: challenges and future prospects.高雪氏病中多能干细胞技术的当前观点:挑战与未来前景
Cytotechnology. 2025 Feb;77(1):26. doi: 10.1007/s10616-024-00687-2. Epub 2024 Dec 27.
3
Lysosomal membrane integrity in fibroblasts derived from patients with Gaucher disease.戈谢病患者成纤维细胞中的溶酶体膜完整性。

本文引用的文献

1
An in vivo model of human small intestine using pluripotent stem cells.利用多能干细胞建立人类小肠的体内模型。
Nat Med. 2014 Nov;20(11):1310-4. doi: 10.1038/nm.3737. Epub 2014 Oct 19.
2
CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findings.戈谢病3型治疗11年后中枢神经系统、肺部及淋巴结受累情况:临床、组织病理学及生化检查结果
Mol Genet Metab. 2015 Feb;114(2):233-241. doi: 10.1016/j.ymgme.2014.08.011. Epub 2014 Sep 2.
3
iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis.
Cell Struct Funct. 2024 Jan 23;49(1):1-10. doi: 10.1247/csf.23066. Epub 2023 Dec 9.
4
Glucocerebrosidase mutations disrupt the lysosome and now the mitochondria.葡萄糖脑苷脂酶突变破坏了溶酶体,现在又破坏了线粒体。
Nat Commun. 2023 Oct 11;14(1):6383. doi: 10.1038/s41467-023-42107-7.
5
Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology.探索通过 CRISPR/Cas9 技术生成的戈谢病单核细胞中导致破骨细胞生成激活的病理生理级联反应。
Int J Mol Sci. 2023 Jul 7;24(13):11204. doi: 10.3390/ijms241311204.
6
iPSC-derived neural precursor cells engineering recovers acid β-glucosidase deficiency and diminishes α-synuclein and neuropathology.诱导多能干细胞衍生的神经前体细胞工程可恢复酸性β-葡萄糖苷酶缺乏,并减少α-突触核蛋白和神经病理学变化。
Mol Ther Methods Clin Dev. 2023 Mar 15;29:185-201. doi: 10.1016/j.omtm.2023.03.007. eCollection 2023 Jun 8.
7
Generation and characterization of motor neuron progenitors and motor neurons using metachromatic leukodystrophy-induced pluripotent stem cells.利用异染性脑白质营养不良诱导多能干细胞生成运动神经元祖细胞和运动神经元并进行表征
Mol Genet Metab Rep. 2022 Feb 21;31:100852. doi: 10.1016/j.ymgmr.2022.100852. eCollection 2022 Jun.
8
Purine nucleoside phosphorylase deficiency induces p53-mediated intrinsic apoptosis in human induced pluripotent stem cell-derived neurons.嘌呤核苷磷酸化酶缺乏诱导人诱导多能干细胞源性神经元中 p53 介导的内在凋亡。
Sci Rep. 2022 May 31;12(1):9084. doi: 10.1038/s41598-022-10935-0.
9
Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson's disease.迈向具有生理相关性的帕金森病人类多能干细胞(hPSC)模型。
Stem Cell Res Ther. 2021 Apr 29;12(1):253. doi: 10.1186/s13287-021-02326-5.
10
Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review.葡萄糖脑苷脂(溶酶体脑苷脂)作为戈谢病生物标志物的价值:系统文献综述。
Int J Mol Sci. 2020 Sep 28;21(19):7159. doi: 10.3390/ijms21197159.
源自 GBA1 相关帕金森病患者的 iPSC 神经元显示自噬缺陷和钙稳态受损。
Nat Commun. 2014 Jun 6;5:4028. doi: 10.1038/ncomms5028.
4
Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.戈谢病诱导多能干细胞衍生的巨噬细胞产生高水平的炎症介质,并作为治疗开发的新平台。
Stem Cells. 2014 Sep;32(9):2338-49. doi: 10.1002/stem.1732.
5
Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1.通过突变型SOD1基因校正鉴定出的人类肌萎缩侧索硬化症运动神经元中被破坏的信号通路。
Cell Stem Cell. 2014 Jun 5;14(6):781-95. doi: 10.1016/j.stem.2014.03.004. Epub 2014 Apr 3.
6
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.多种致病蛋白与神经元型戈谢病小鼠有关。
Hum Mol Genet. 2014 Aug 1;23(15):3943-57. doi: 10.1093/hmg/ddu105. Epub 2014 Mar 5.
7
Unfolded protein response in Gaucher disease: from human to Drosophila.戈谢氏病中的未折叠蛋白反应:从人类到果蝇。
Orphanet J Rare Dis. 2013 Sep 11;8:140. doi: 10.1186/1750-1172-8-140.
8
Expression of human Gaucher disease gene GBA generates neurodevelopmental defects and ER stress in Drosophila eye.人戈谢病基因 GBA 的表达导致果蝇眼的神经发育缺陷和内质网应激。
PLoS One. 2013 Aug 2;8(8):e69147. doi: 10.1371/journal.pone.0069147. Print 2013.
9
Mitochondria and quality control defects in a mouse model of Gaucher disease--links to Parkinson's disease.戈谢氏病小鼠模型中线粒体和质量控制缺陷——与帕金森病的关联。
Cell Metab. 2013 Jun 4;17(6):941-953. doi: 10.1016/j.cmet.2013.04.014. Epub 2013 May 23.
10
Remodeling the proteostasis network to rescue glucocerebrosidase variants by inhibiting ER-associated degradation and enhancing ER folding.通过抑制内质网相关降解和增强内质网折叠来重塑蛋白稳态网络,以挽救葡萄糖脑苷脂酶变异体。
PLoS One. 2013 Apr 19;8(4):e61418. doi: 10.1371/journal.pone.0061418. Print 2013.